CI: Donepezil and galantamine interact with cytochrome P450, caution with Beta blockers, CCB, NSAIDs
PtC: donepezil has long half life allowing for once daily dosing, rivastigmine in tablet or 24 hr transdermal patch
NMDA antagonist: Memantine
aka Namenda
MOA: antagonist w/ low affinity at NMDA receptor, blockade slows the intracellular calcium accumulation and helps prevent further nerve damage AND may prevent excitatory AA neurotoxicity w/o interfering with the physiological actions of glutamate required for memory and learning
AE: well tolerated, confusion, agitation, restlessness, constipation, dizziness, headache
CI: caution in seizures or hepatic impairment
PtC: dosage adjustment for CrCl <30
Clinical use: moderate to severe disease, monotherapy or add to acetylcholinesterase inhibitor